Preprint
Validation of a commercially available SARS-CoV-2 serological Immunoassay
Abstract
Abstract Objectives To validate the diagnostic accuracy of a Euroimmun SARS-CoV-2 IgG and IgA immunoassay for COVID-19. Methods In this unmatched (1:1) case-control validation study, we used sera of 181 laboratory-confirmed SARS-CoV-2 cases and 176 controls collected before SARS-CoV-2 emergence. Diagnostic accuracy of the immunoassay was assessed against a whole spike protein-based recombinant immunofluorescence assay (rIFA) by receiver …
Authors
Meyer B; Torriani G; Yerly S; Mazza L; Calame A; Arm-Vernez I; Zimmer G; Agoritsas T; Stirnemann J; Spechbach H
DOI
10.1101/2020.05.02.20080879
Preprint server
medRxiv